Clinical Study to Evaluate Different Energy-based Devices for Aesthetic Treatments.

Exclusion Criteria

• •Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period.
• •Takes or has taken oral isotretinoin, such as Accutane®, within the last six months.
• •Is using systemic steroids (e.g., prednisone, dexamethasone) prior to or during the course of treatment.
• •Is receiving or has received gold therapy.
• •Is taking medications that alter the wound-healing response or has a history of healing problems.
• •Has an active localized or systemic infection, or an open wound in area being treated.
• •Has a significant systemic illness, such as lupus, or an illness localized in area being treated.
• •Has a seizure disorders triggered by light.
• •Has a history of skin photosensitivity disorders.
• •Has a history of hypertrophic scars or keloid formation.
• •Has a history of radiation therapy in area to be treated.
• •Received fillers or neurotoxin injections in the treatment area within the past 2 weeks.
• •Has had a chemical or mechanical epilation within the last six weeks.
• •Currently enrolled in an investigational drug or device trial or has received an investigational drug or been treated with an investigational device within the area to be treated 6 months to entering this study.
• •Has any condition or is in a situation which in the investigator's opinion may put the subject at significant risk, may confound study results or may interfere significantly with the subject's participation.
• •Radiofrequency Device Only:
• •Has a Pacemaker
• •Has any embedded electronic devices that give or receive a signal.
• •Has electronic implants, such as Implantable Cardiac Defibrillators (ICD) or Cardiac Resynchronization Therapy (CRT) devices: treatment may interfere with the functionality of the device and/or damage the electronic implant.
• •Is allergic to adhesives such as glues on medical tape: they should be alerted that a rash may occur on the neutral electronic monitoring pad (NEM or neutral pad) site, and an over-the-counter preparation may be used to treat the area.
• •Has nerve insensitivity to heat in the treatment area or in the neutral pad placement area.
• •Is allergic to topical anesthetic